Submitted by Anonymous (not verified) on 2 August 2023 - 14:08
Twelfth Paediatric Oncology Strategy Forum for Medicinal Product Development of CDK4/6, CDK7 and CDK9 Inhibitors in children and adolescents, Hybrid, from 26/10/2023 to 27/10/2023
Source: